Researchers at Tel Aviv University have proved that the medication Davunetide may significantly slow the progression of progressive supranuclear palsy (PSP) in women. PSP is a rare and fatal neurodegenerative disease due to abnormal accumulation of tau protein in the brain.
Treatment for fatal brain disease
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.